Clinical Trial Update: A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa trial evaluating GM-XANTHO in healthy volunteers and patients with atopic dermatitis has been completed. The study was conducted by Xantho Biotechno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GM-XANTHO

Snippet

Sponsor: Xantho Biotechnology Co., LTD | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED